U.S. Physical Therapy (USPH) Expected to Announce Earnings on Wednesday

U.S. Physical Therapy (NYSE:USPH) will likely be releasing its Q3 2025 results after the market closes on Wednesday, November 5th. Analysts expect U.S. Physical Therapy to post earnings of $0.67 per share and revenue of $193.9760 million for the quarter. Parties may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, November 6, 2025 at 10:30 AM ET.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Tuesday, August 22nd. The company reported $0.90 earnings per share (EPS) for the quarter. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The firm had revenue of $140.66 million during the quarter. On average, analysts expect U.S. Physical Therapy to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

U.S. Physical Therapy Stock Performance

NYSE USPH opened at $86.18 on Monday. U.S. Physical Therapy has a 1 year low of $62.77 and a 1 year high of $101.19. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.18. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of 37.63, a PEG ratio of 4.41 and a beta of 1.48. The company has a fifty day moving average price of $85.56 and a 200-day moving average price of $79.61.

U.S. Physical Therapy Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, September 12th. Stockholders of record on Friday, August 22nd were paid a $0.45 dividend. The ex-dividend date was Friday, August 22nd. This represents a $1.80 annualized dividend and a dividend yield of 2.1%. U.S. Physical Therapy’s dividend payout ratio is presently 78.60%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Nancy Ham sold 600 shares of the company’s stock in a transaction dated Thursday, September 11th. The shares were sold at an average price of $81.71, for a total transaction of $49,026.00. Following the sale, the director directly owned 1,994 shares of the company’s stock, valued at $162,929.74. This represents a 23.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Carey P. Hendrickson sold 698 shares of the company’s stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $86.11, for a total transaction of $60,104.78. Following the sale, the chief financial officer directly owned 27,808 shares in the company, valued at approximately $2,394,546.88. This trade represents a 2.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 6,853 shares of company stock valued at $581,406. Insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On U.S. Physical Therapy

Institutional investors have recently added to or reduced their stakes in the business. Daiwa Securities Group Inc. lifted its holdings in U.S. Physical Therapy by 50.8% during the second quarter. Daiwa Securities Group Inc. now owns 24,230 shares of the company’s stock valued at $1,895,000 after purchasing an additional 8,158 shares during the last quarter. First Trust Advisors LP lifted its holdings in shares of U.S. Physical Therapy by 3.7% in the second quarter. First Trust Advisors LP now owns 10,725 shares of the company’s stock worth $839,000 after buying an additional 385 shares in the last quarter. Jane Street Group LLC lifted its holdings in shares of U.S. Physical Therapy by 249.3% in the first quarter. Jane Street Group LLC now owns 49,309 shares of the company’s stock worth $3,568,000 after buying an additional 35,191 shares in the last quarter. Royal Bank of Canada lifted its holdings in shares of U.S. Physical Therapy by 3.4% in the first quarter. Royal Bank of Canada now owns 79,238 shares of the company’s stock worth $5,733,000 after buying an additional 2,594 shares in the last quarter. Finally, Osaic Holdings Inc. lifted its holdings in shares of U.S. Physical Therapy by 1.6% in the second quarter. Osaic Holdings Inc. now owns 10,447 shares of the company’s stock worth $817,000 after buying an additional 166 shares in the last quarter.

Analyst Ratings Changes

USPH has been the subject of several recent analyst reports. Wall Street Zen lowered shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Sunday, September 21st. Weiss Ratings reiterated a “hold (c)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, October 8th. Barrington Research reiterated an “outperform” rating and issued a $103.00 target price on shares of U.S. Physical Therapy in a research note on Friday, October 24th. JPMorgan Chase & Co. started coverage on shares of U.S. Physical Therapy in a research report on Thursday, September 18th. They set an “overweight” rating and a $110.00 price target for the company. Finally, Zacks Research upgraded shares of U.S. Physical Therapy to a “hold” rating in a research report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $110.25.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.